New therapy aims to ease cancer Survivors' fear of return

NCT ID NCT06676228

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study adapted a 6-session behavioral therapy called FORT for Turkish breast and ovarian cancer survivors to help them manage fear of cancer recurrence. Researchers worked with 100 participants to translate and test the therapy, measuring changes in fear, anxiety, and quality of life. The goal is to provide a culturally suitable tool to support survivors' mental health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fear of cancer recurrence therapy (FORT) - a 6-session behavioral intervention
What this could lead to
If successful, this culturally adapted therapy could provide an effective way to reduce fear of cancer recurrence and improve mental well-being for Turkish cancer survivors.
What could go wrong
This is a small, completed cultural adaptation study with 100 participants, so results may not apply broadly. The therapy's long-term benefits beyond 6 months are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Maltepe University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.